Skip to main content
Clinical Trials/ISRCTN07355119
ISRCTN07355119
Completed
Phase 3

A randomised trial to evaluate whether treatment can be reduced without compromising effficacy in a low risk group of patients defined by a molecular minimal residual disease (MRD) technique; and to evaluate whether further post-remission intensification can improve outcome for a MRD-defined high risk group

niversity of Sheffield (UK)0 sites2,500 target enrollmentAugust 18, 2003

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
eukaemia
Sponsor
niversity of Sheffield (UK)
Enrollment
2500
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Registry
who.int
Start Date
August 18, 2003
End Date
June 30, 2011
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Sheffield (UK)

Eligibility Criteria

Inclusion Criteria

  • Children aged 1 \- 18 years with ALL
  • As of 12/02/2010, young adults up to their 25th birthday are also eligible for this trial.

Exclusion Criteria

  • 1\. Mature B ALL
  • 2\. Infant ALL (aged less than 1 year)
  • 3\. Philadelphia positive ALL

Outcomes

Primary Outcomes

Not specified

Similar Trials